Sarcopenia, or loss of skeletal muscle, is a progressive and life-threatening condition commonly observed in the elderly. Treatment of sarcopenia involves intramuscular injections of anabolic hormones, dietary supplements and prescription drugs that help increase muscle mass and strength. The rapidly aging population across the globe has fueled the demand for sarcopenia treatment.
Market key trends:
The increased geriatric population, which is more susceptible to sarcopenia, has been a key driver of the sarcopenia treatment market over the past few years. It is estimated that the population aged over 65 years will double from 524 million in 2010 to approximately 1.5 billion in 2050 globally. With advanced age comes an increased risk of age-related muscle loss. Most countries currently experience an expansion of their geriatric demographic and this rapid growth is expected to continue over the forecast period, thereby significantly augmenting the demand for sarcopenia treatment drugs and supplements. Furthermore, rising awareness about the condition and availability of various treatment options fuels the market growth.
Segment Analysis
Sarcopenia treatment market is segmented based on treatment type into vitamin D and calcium supplements, protein supplements, and exercise. The exercise segment is expected to dominate the market during the forecast period as regular exercise is considered as the most effective way to improve muscle strength and physical performance. Exercise helps in increasing muscle mass and strength by creating micro-tears in the muscles that stimulate muscle growth when repaired.
Key Takeaways
The Global Sarcopenia Treatment Market Size is expected to witness high growth during the forecast period of 2024-2031.
Regional analysis: North America region currently dominates the sarcopenia treatment market owing to rising geriatric population and increasing awareness about sarcopenia treatment. Asia Pacific region is expected to be the fastest growing market due to improving healthcare infrastructure and increasing healthcare expenditure in countries like China and India.
Key players operating in the sarcopenia treatment market are Yokogawa, General Electric, Rockwell Automation, MAVERICK Technologies, Emerson, Siemens, Rudolph Technologies, Honeywell International, ABB, Schneider Electric, Aspen Technology. Yokogawa dominates the market owing to its wide product portfolio and strong distribution network across various regions.
Explore more information on this topic, Please visit -
https://www.insightprobing.com/sarcopenia-treatment-market-outlook-and-forecasts-analysis/
Explore more trending article related this topic -
https://www.insightprobing.com/cancer-biomarkers-market-share-and-demand-analysis-2/
Comments
0 comment